The psychomotor effects of paroxetine alone and in combination with haloperidol, amylobarbitone, oxazepam, or alcohol.
Cooper
S M
SM
Beecham Pharmaceuticals Research Division, Medicinal Research Centre, Harlow, Essex, United Kingdom.
Jackson
D
D
Loudon
J M
JM
McClelland
G R
GR
Raptopoulos
P
P
D000328:Adult; D000654:Amobarbital / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000494:pharmacology*; D001143:Arousal / Q000187:drug effects*; D004311:Double-Blind Method; D000431:Ethanol / Q000494:pharmacology*; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010076:Oxazepam / Q000494:pharmacology*; D017374:Paroxetine; D010880:Piperidines / Q000494:pharmacology*; D011597:Psychomotor Performance / Q000187:drug effects*; D016032:Randomized Controlled Trials as Topic; D011930:Reaction Time / Q000187:drug effects; D012702:Serotonin Antagonists / Q000494:pharmacology*
D000928:Antidepressive Agents; D010880:Piperidines; D012702:Serotonin Antagonists; D000431:Ethanol; D017374:Paroxetine; D010076:Oxazepam; D000654:Amobarbital; D006220:Haloperidol